Its approved to treat adults and pediatric patients 12 years and older with obesity who weigh more than 60 kg (132 pounds)
The primary endpoint is a renal composite episode defined by a decrease in GFR 50%, end-stage renal failure, and death from a renal-cause or cardiovascular-caused death, and it is scheduled for completion in 2024
The feta cheese and the olive oil based dressing contain healthy fats to bring this whole meal together
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
Can patients use GLP-1 agonists and SGLT2 inhibitors together
Everyone deserves care that is holistic, respectful, and tailored to their full lived experience